Validation of Metagenomic Next-Generation Sequencing Tests for Universal Pathogen Detection

Area of Science:

• Microbiology
• Genomics
• Clinical Diagnostics

Background:

• Metagenomic sequencing, utilizing unbiased shotgun next-generation sequencing (NGS), enables pathogen detection without sequence-specific amplification.
• Proof-of-concept studies have shown utility in unknown infectious disease outbreaks and in patients with negative conventional test results.
• Metagenomic NGS tests show significant potential for enhancing infectious disease diagnostics, particularly in immunocompromised and critically ill individuals.

Purpose of the Study:

• To address the challenges associated with validating metagenomic pathogen detection assays in clinical laboratory settings.
• To offer practical solutions and insights for assay validation, drawing from real-world examples.
• To summarize current regulatory requirements for NGS testing, referencing existing guidelines in genetics and oncology.

Main Methods:

• Validation of assay design, encompassing both wet bench procedures and bioinformatics protocols.
• Implementation of quality control and assurance measures throughout the validation process.
• Illustrative examples from two distinct validation studies to demonstrate practical application.

Main Results:

• Metagenomic NGS tests for infectious diseases are increasingly undergoing validation in clinical laboratories.
• Despite complexity, laboratory and data analysis workflows are becoming more streamlined.
• Parallels exist with NGS test validation in other scientific fields.

Conclusions:

• Specimen preparation, evolving bioinformatics algorithms, and incomplete reference databases are unique challenges in metagenomic microbiology.
• Successful validation of metagenomic NGS tests is crucial for advancing infectious disease diagnostics.
• Continued development and standardization are necessary to overcome field-specific hurdles.